Kyntra Bio
KYNB
76 hedge funds and large institutions have $500M invested in Kyntra Bio in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 8 closing their positions.
125% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 8
63% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 16
17% more capital invested
Capital invested by funds: $426M → $500M (+$74M)
15% more funds holding
Funds holding: 66 → 76 (+10)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.4M |
| 2 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$11.5M |
| 3 |
Citigroup
New York
|
+$1.76M |
| 4 |
GAM
Gotham Asset Management
New York
|
+$1.27M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.69M |
| 2 |
JP Morgan Chase
New York
|
-$8.74M |
| 3 |
DP
DSAM Partners
London,
United Kingdom
|
-$3.5M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.18M |
| 5 |
Morgan Stanley
New York
|
-$1.17M |
KYNB Hedge Fund Activity: Q1 2015 in Review
76 of the 3,769 institutional investors tracked by Wall St. Rank reported a position in Kyntra Bio (KYNB) for Q1 2015, worth a combined $500M — up 17% from $426M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new KYNB positions and 8 closed out — a net gain of 10 holders — while 26 added to existing stakes and 16 trimmed.
The largest buyer was Vanguard Group, adding an estimated $14.4M. The largest seller was Fidelity Investments, cutting an estimated $9.69M.
- 76 institutional investors held Kyntra Bio (KYNB) as of Q1 2015, up from 66 in Q4 2014.
- Funds reported $500M of Kyntra Bio stock for Q1 2015, up 17% quarter-over-quarter.
- 18 funds opened new Kyntra Bio positions in Q1 2015 and 8 closed out, a net change of +10 holders.
- The largest Kyntra Bio buyer in Q1 2015 was Vanguard Group, an estimated $14.4M added.
- The largest Kyntra Bio seller in Q1 2015 was Fidelity Investments, an estimated $9.69M sold.
Based on aggregated 13F filings for Q1 2015.